COST-EFFECTIVENESS OF POST-TREATMENT FOLLOW-UP AND SECONDARY PREVENTION OF TUBERCULOSIS IN A HIGH-INCIDENCE SETTING - A MODEL-BASED ANALYSIS

被引：0
|
作者：
Marx, Florian [1 ]
Cohen, Ted [2 ]
Menzies, Nicolas [3 ]
Salomon, Joshua [4 ,5 ]
Yaesoubi, Reza [2 ]
机构：
[1] DST NRF South African Ctr Excellence Epidemiol M, Stellenbosch, South Africa
[2] Yale Sch Publ Hlth, New Haven, CT USA
[3] Harvard TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA USA
[4] Ctr Hlth Policy, Stanford, CA USA
[5] Ctr Primary Care & Outcomes Res, Stanford, CA USA
来源：
MEDICAL DECISION MAKING | 2020年 / 40卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
5N-6
引用
收藏
页码：E360 / E361
页数：2
相关论文
共 50 条
  • [1] Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting: a model-based analysis
    Marx, Florian M.
    Cohen, Ted
    Menzies, Nicolas A.
    Salomon, Joshua A.
    Theron, Grant
    Yaesoubi, Reza
    LANCET GLOBAL HEALTH, 2020, 8 (09): : E1223 - E1233
  • [2] Cost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis
    G. B. Gomez
    D. W. Dowdy
    M. L. Bastos
    A. Zwerling
    S. Sweeney
    N. Foster
    A. Trajman
    M. A. Islam
    S. Kapiga
    E. Sinanovic
    G. M. Knight
    R. G. White
    W. A. Wells
    F. G. Cobelens
    A. Vassall
    BMC Infectious Diseases, 16
  • [3] Cost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis
    Gomez, G. B.
    Dowdy, D. W.
    Bastos, M. L.
    Zwerling, A.
    Sweeney, S.
    Foster, N.
    Trajman, A.
    Islam, M. A.
    Kapiga, S.
    Sinanovic, E.
    Knight, G. M.
    White, R. G.
    Wells, W. A.
    Cobelens, F. G.
    Vassall, A.
    BMC INFECTIOUS DISEASES, 2016, 16
  • [4] Targeting screening and treatment for latent tuberculosis infection towards asylum seekers from high-incidence countries - a model-based cost-effectiveness analysis
    Marx, Florian M.
    Hauer, Barbara
    Menzies, Nicolas A.
    Haas, Walter
    Perumal, Nita
    BMC PUBLIC HEALTH, 2021, 21 (01)
  • [5] Targeting screening and treatment for latent tuberculosis infection towards asylum seekers from high-incidence countries – a model-based cost-effectiveness analysis
    Florian M. Marx
    Barbara Hauer
    Nicolas A. Menzies
    Walter Haas
    Nita Perumal
    BMC Public Health, 21
  • [6] Active screening for tuberculosis in high-incidence Inuit communities in Canada: a cost-effectiveness analysis
    Uppal, Aashna
    Nsengiyumva, Ntwali Placide
    Signor, Celine
    Jean-Louis, Frantz
    Rochette, Marie
    Snowball, Hilda
    Etok, Sandra
    Annanack, David
    Ikey, Julie
    Khan, Faiz Ahmad
    Schwartzman, Kevin
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (43) : E1652 - E1659
  • [7] Framework for the Cost-Effectiveness of Secondary Prevention Strategies in Cardiovascular Diseases: A Canadian Theoretical Model-Based Analysis
    Fanton-Aita, Fiorella
    Matteau, Alexis
    Mitchell, Dominic
    Potter, Brian J.
    Iliza, Ange Christelle
    Guertin, Jason R.
    Dubois, Anick
    Dube, Marie-Pierre
    Tardif, Jean-Claude
    LeLorier, Jacques
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 353 - 353
  • [8] A scoping review of cost-effectiveness of screening and treatment for latent tuberculosis infection in migrants from high-incidence countries
    Lorenzo Zammarchi
    Gianluigi Casadei
    Marianne Strohmeyer
    Filippo Bartalesi
    Carola Liendo
    Alberto Matteelli
    Maurizio Bonati
    Eduardo Gotuzzo
    Alessandro Bartoloni
    BMC Health Services Research, 15
  • [9] The model-based cost-effectiveness analysis of 1-year adjuvant trastuzumab treatment: based on 2-year follow-up HERA trial data
    Shiroiwa, Takeru
    Fukuda, Takashi
    Shimozuma, Kojiro
    Ohashi, Yasuo
    Tsutani, Kiichiro
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 109 (03) : 559 - 566
  • [10] The model-based cost-effectiveness analysis of 1-year adjuvant trastuzumab treatment: based on 2-year follow-up HERA trial data
    Takeru Shiroiwa
    Takashi Fukuda
    Kojiro Shimozuma
    Yasuo Ohashi
    Kiichiro Tsutani
    Breast Cancer Research and Treatment, 2008, 109 : 559 - 566
12345